These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33070375)

  • 1. Cytokine profiles and clinical characteristics in primary Sjögren´s syndrome patient groups.
    López-Villalobos EF; Muñoz-Valle JF; Palafox-Sánchez CA; García-Arellano S; Martínez-Fernández DE; Orozco-Barocio G; García-Espinoza JA; Oregon-Romero E
    J Clin Lab Anal; 2021 Feb; 35(2):e23629. PubMed ID: 33070375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salivary cytokine profiles in primary Sjögren's syndrome differ from those in non-Sjögren sicca in terms of TNF-α levels and Th-1/Th-2 ratios.
    Kang EH; Lee YJ; Hyon JY; Yun PY; Song YW
    Clin Exp Rheumatol; 2011; 29(6):970-6. PubMed ID: 22132900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatigue in primary Sjögren's syndrome (pSS) is associated with lower levels of proinflammatory cytokines: a validation study.
    Davies K; Mirza K; Tarn J; Howard-Tripp N; Bowman SJ; Lendrem D; ; Ng WF
    Rheumatol Int; 2019 Nov; 39(11):1867-1873. PubMed ID: 31250166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smoking, disease characteristics and serum cytokine levels in patients with primary Sjögren's syndrome.
    Olsson P; Skogstrand K; Nilsson A; Turesson C; Jacobsson LTH; Theander E; Houen G; Mandl T
    Rheumatol Int; 2018 Aug; 38(8):1503-1510. PubMed ID: 29846789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro effects of curcumin on proinflammatory cytokines and expression of their genes in minor salivary gland tissue of patients with Sjogren's syndrome.
    Kabeerdoss J; Sandhya P; Kurien BT; Scofield RH; Danda D
    Rheumatol Int; 2022 Mar; 42(3):545-551. PubMed ID: 33861386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression of death decoy receptor 3 was increased in the patients with primary Sjögren's syndrome.
    Liu J; Zhao Z; Zou Y; Zhang M; Zhou Y; Li Y; Pang Z; Jin W
    Clin Rheumatol; 2015 May; 34(5):879-85. PubMed ID: 25564309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe intestinal dysbiosis is prevalent in primary Sjögren's syndrome and is associated with systemic disease activity.
    Mandl T; Marsal J; Olsson P; Ohlsson B; Andréasson K
    Arthritis Res Ther; 2017 Oct; 19(1):237. PubMed ID: 29065905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships between increased circulating YKL-40, IL-6 and TNF-α levels and phenotypes and disease activity of primary Sjögren's syndrome.
    Chen C; Liang Y; Zhang Z; Zhang Z; Yang Z
    Int Immunopharmacol; 2020 Nov; 88():106878. PubMed ID: 32791244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Transcriptome of Paired Major and Minor Salivary Gland Tissue in Patients With Primary Sjögren's Syndrome.
    Verstappen GM; Gao L; Pringle S; Haacke EA; van der Vegt B; Liefers SC; Patel V; Hu Y; Mukherjee S; Carman J; Menard LC; Spijkervet FKL; Vissink A; Bootsma H; Kroese FGM
    Front Immunol; 2021; 12():681941. PubMed ID: 34295332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease activity and damage in patients with primary Sjogren's syndrome: Prognostic value of salivary gland ultrasonography.
    Milic V; Colic J; Cirkovic A; Stanojlovic S; Damjanov N
    PLoS One; 2019; 14(12):e0226498. PubMed ID: 31891590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of BAFF and BAFF receptors in primary Sjögren's syndrome patients with ectopic germinal center-like structures.
    Carrillo-Ballesteros FJ; Palafox-Sánchez CA; Franco-Topete RA; Muñoz-Valle JF; Orozco-Barocio G; Martínez-Bonilla GE; Gómez-López CE; Marín-Rosales M; López-Villalobos EF; Luquin S; Castañeda-Chávez A; Oregon-Romero E
    Clin Exp Med; 2020 Nov; 20(4):615-626. PubMed ID: 32506205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Interleukin-17F is Associated with Elevated Autoantibody Levels and More Clinically Relevant Than Interleukin-17A in Primary Sjögren's Syndrome.
    Gan Y; Zhao X; He J; Liu X; Li Y; Sun X; Li Z
    J Immunol Res; 2017; 2017():4768408. PubMed ID: 28210632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased circulating CXCR3 + CCR9+T helper cells are associated with elevated levels of their ligands CXCL10 and CCL25 in the salivary gland of patients with Sjögren's syndrome to facilitate their concerted migration.
    Blokland SLM; Kislat A; Homey B; Smithson GM; Kruize AA; Radstake TRDJ; van Roon JAG
    Scand J Immunol; 2020 Mar; 91(3):e12852. PubMed ID: 31733111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salivary gland secretome: a novel tool towards molecular stratification of patients with primary Sjögren's syndrome and non-autoimmune sicca.
    Blokland SLM; Hillen MR; van Vliet-Moret FM; Bikker A; de Jager W; Pandit A; Kruize AA; Radstake TRDJ; van Roon JAG
    RMD Open; 2019; 5(1):e000772. PubMed ID: 30713719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive analysis of the clinical manifestations and hematological parameters associated with secondary immune thrombocytopenia in patients with primary Sjögren syndrome: An observational study.
    Yang W
    Medicine (Baltimore); 2024 May; 103(19):e37909. PubMed ID: 38728456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between systemic activity ındex and dry eye severity in patients with primary Sjögren syndrome.
    Ozek D; Kemer OE; Omma A
    Arq Bras Oftalmol; 2019; 82(1):45-50. PubMed ID: 30403265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Interleukin 33/ST2 axis in patients with primary Sjögren syndrome: expression in serum and salivary glands, and the clinical association.
    Jung SM; Lee J; Baek SY; Lee JH; Lee J; Park KS; Park SH; Kim HY; Kwok SK
    J Rheumatol; 2015 Feb; 42(2):264-71. PubMed ID: 25512474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic analysis of saliva: a unique tool to distinguish primary Sjögren's syndrome from secondary Sjögren's syndrome and other sicca syndromes.
    Baldini C; Giusti L; Ciregia F; Da Valle Y; Giacomelli C; Donadio E; Sernissi F; Bazzichi L; Giannaccini G; Bombardieri S; Lucacchini A
    Arthritis Res Ther; 2011; 13(6):R194. PubMed ID: 22117835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuro-Sjögren: Peripheral Neuropathy With Limb Weakness in Sjögren's Syndrome.
    Seeliger T; Prenzler NK; Gingele S; Seeliger B; Körner S; Thiele T; Bönig L; Sühs KW; Witte T; Stangel M; Skripuletz T
    Front Immunol; 2019; 10():1600. PubMed ID: 31354737
    [No Abstract]   [Full Text] [Related]  

  • 20. Elevation of Serum IL-35 in Patients with Primary Sjögren's Syndrome.
    Han M; Li Y; Liu S; Jiang S; Yuan L; Xia L; Shen H; Lu J
    J Interferon Cytokine Res; 2018 Oct; 38(10):452-456. PubMed ID: 30256702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.